BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2006
View Archived Issues
Preclinical profile of PHA-680632 reported
Read More
AIM results detail abatacept efficacy in methotrexate-resistant rheumatoid arthritis
Read More
Lilly report on LY-2434074, a novel brain penetrating BACE1 inhibitor
Read More
Ixabepilone activity modest in patients with gastric cancer
Read More
Merck & Co. improves BACE1 inhibitor
Read More
Dainippon Sumitomo and Bristol-Myers enter into Japanese licensing agreements
Read More
TPM-02/Insulin studied in phase I trial
Read More
Treatment completed in phase I stem cell study of CB-001
Read More
Oscient to acquire Antara U.S. rights
Read More
Altus faces delays to initiation of phase III trials for ALTU-135 and ALTU-238
Read More
Accentia amends chronic sinusitis option agreement with Mayo Clinic
Read More
Nektar receives payment under Affymax partnership
Read More
Completion of phase IIa study of arimoclomol in ALS
Read More
Antares Pharma and Population Council to develop topical Nestorone product
Read More
Peptidomimetics derived from APP as a novel therapeutic strategy for AD
Read More
TG-C begins phase I trial for treatment of degenerative joint diseases
Read More
Sirion Therapeutics licenses U.S. rights to ophthalmic compound
Read More
RSD-1235 (oral) 300 mg shows trend towards efficacy in recurrent atrial fibrillation
Read More
AC-100 warrants further study for periodontal defects
Read More
Oncaspar approved in first-line treatment for ALL
Read More
Evoltra launched for ALL in U.K.
Read More
Novel C5a receptor inhibitor JPE-1375 improves allograft survival in mice
Read More
New CCR5 receptor antagonist from Incyte prevents cardiac allograft vasculopathy
Read More
Recent patents disclose novel antiinfective agents
Read More
Novel analgesic agents imparted in recent patent literature
Read More
Recent GSK patent describes novel diagnostic agents
Read More